| open-label trial | A study in which both researchers and participants know what drug a person is taking and at what dose. (09 Oct 1997) |
|---|
| open-label study |
A preliminary (Phase I) clinical trial in which all patients receive the experimental treatment.
Ãâó: www.nationalmssociety.org/O%20-%20R.asp
|
|---|---|
| open-label study |
study in which subjects and investigators know which agent is being administered to each group during the trial period
Ãâó: www.venofer.com/VenoferHCP/Venofer_glossary.html
|
| open-label study |
An experimental study involving the use of a medicine, the identity of which is known to the patient.
Ãâó:
|
| open-label study |
A study in which all parties, (patient, physician and study coordinator) are informed of the drug and dose being administered. In an open-label study, none of the participants are given placebos. These are usually conducted with Phase I & II studies.
Ãâó: www.wcctrials.com/glossary.HTM
|
| open-label study |
A study in which the investigator and the study participant are aware of the drug therapy received during the study.
Ãâó: www.lillytrials.com/docs/terminology.html
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|